Spero Therapeutics logo
Spero Therapeutics SPRO
$ 1.18 -1.26%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Spero Therapeutics EV/EBITDA Ratio 2011-2024 | SPRO

Annual EV/EBITDA Ratio Spero Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.55 -3.11 -2.34 -2.79 1.33 - -4.39 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.33 -4.39 -2.47